In Vitro Effects of Cyclosporine A and Tacrolimus on Regulatory T-Cell Proliferation and Function
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Liver transplantation is the treatment of end-stage liver diseases, including hepatitis C. Immunosuppression prevents graft rejection but seems to accelerate the recurrence of hepatitis C. Regulatory T cells (Tregs) may be beneficial in tolerance but deleterious in recurrent hepatitis C. We evaluated the effects of cyclosporine or tacrolimus, the principal immunosuppressive drugs, on Treg proliferation and function. METHODS: Human Tregs were isolated from healthy donors and cultured with cyclosporine, tacrolimus, or NIM811, a cyclosporine analog devoid of calcineurin-inhibiting activity. Treg proliferation and suppressive activity were assessed. The phenotype, cytokine production, and phosphorylation profile of nuclear factor of activated T cell of Tregs were also analyzed. RESULTS: Cyclosporine and tacrolimus both decreased Treg proliferation, but only low doses of cyclosporine reduced Treg activity, by inducing the production of interleukin 2 proinflammatory cytokines in these cells. Moreover, NIM811 also inhibited Treg activity. The phosphorylation of nuclear factor of activated T cell in Tregs was not altered by cyclosporine, suggesting that the effects of this drug are independent of the calcineurin pathway. CONCLUSION: In summary, low doses of cyclosporine inhibit Treg activity, a finding that might explain the beneficial effect of this drug on hepatitis C recurrence. In contrast, by maintaining Treg activity, tacrolimus could be more helpful than cyclosporine in controlling rejection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“one study showed that ciclosporin and tacrolimus inhibited Tregs proliferation and activation in vitro (60).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [60]
In the citing paper
“Ciclosporin and tacrolimus were found to inhibit Treg proliferation and activity in vitro (79), and similar effects were observed in tacrolimus-treated allograft patients ex vivo (80); this could be detrimental in inhibiting the development of peripheral tolerance following rAAV administration.”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [79]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 1×
“Tregs account for 5% to 10% of peripheral CD4 T cells; they constitutively express CD25 (3), can suppress host immune responses in the context of autoimmune diseases and transplantation (4, 5), and have been shown to be an essential component in immune tolerance (6).”
BackgroundThornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 1×
“The transcription factor FoxP3, expressed by Tregs, seems to be a master gene controlling Treg development (8), most FoxP3 Tregs being CD127/low (9, 10).”
BackgroundA function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“The transcription factor FoxP3, expressed by Tregs, seems to be a master gene controlling Treg development (8), most FoxP3 Tregs being CD127/low (9, 10).”
BackgroundSakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Regulatory T cells and mechanisms of immune system control
O'Garra, A., & Vieira, P. (2004) · Nature Medicine · doi:10.1038/nm0804-801 · Cited by 810
Natural regulatory T cells: mechanisms of suppression
Miyara, M., & Sakaguchi, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.01.003 · Cited by 711
Research works printed but not linked: 2
- OGrady, 2007, Prognostication in acute liver failure: a tool or an anchor Liver T, ranspl, 6, 786
- Berenguer, 2002, Outcome of posttransplantation hepatitis C virus diseaseis it the host, the virus, or how we modify the host andor the virus Liver T, ranspl, 10, 889
Cited by
Items 101–117 of 117
Post-transplant Medication Challenges
Siddiqi, N., & Campbell, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-74783-1_12
CD127 expression in peripheral T cells of pediatric kidney transplant recipients
Salah, D. M., Elshamaa, M. F., Elghoroury, E. A., Kassem, N. M. A., Bazaraa, H. M., Ibrahim, M. F., Galal, A., & Fadel, F. I. (2021) · Pediatria Polska · doi:10.5114/polp.2021.109302
“It was reported previously that CNIs have a markedly negative impact on graft tolerance by affecting Treg function and survival, mainly by interfering with IL-2 production [31, 32].”
BackgroundPark, M.-J., Na, H. S., Joo, Y.-S., Cho, K.-H., Kim, S. Y., Choi, J. W., Baek, J.-A., Choi, J. Y., You, Y. K., & Cho, M. (2020) · doi:10.21203/rs.3.rs-41932/v1
“In addition, FK506 suppressed pro-in ammatory T helper (Th)1/Th17 responses [19, 20] and Foxp3 + Treg [21].”
BackgroundLessons Learned from Clinical Trials of Islet Transplantation
Berney, T., Badet, L., Berishvili, E., Buron, F., Compagnon, P., Haidar, F., Morélon, E., Peloso, A., & Thaunat, O. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_21
A Mini Review on Reproductive Toxicity of Cyclosporine in Male Animals
Oyovwi Mega, O. (2024) · Advances in Clinical Toxicology · doi:10.23880/act-16000307
Expressão dos linfócitos CD4+CD25+ (células T reguladoras) nos pênfigos
de Albuquerque, C. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2014.tde-16072024-154817
Alotaibi, N., Alesawy, A., Alalshaikh, M., Aljofi, F. E., Aldossary, N., Alzahrani, N., Omar, O., & Madi, M. I. (2025) · Frontiers in Oral Health · doi:10.3389/froh.2025.1544821
Biomarkers for drug development in kidney transplantation
Pattanaik, S., & van Gelder, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824069-4.00016-1
Lee, S., Woo, H. T., Lee, H., Choi, G., Joo, K. I., & Chi, H. J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114468 · Cited by 1
The role of exosomes in immune cell function and regulation during organ transplantation
Yang, H., Duan, K., Liu, Z., Chu, T., Liu, H., Gao, B., Liu, X., & Wei, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116044
Zhang, Y., Yan, R., Zhang, D., & Guo, H. (2026) · Xenobiotica · doi:10.1080/00498254.2025.2612030
“As one of the commonly used immunosuppressants in the clinic, tacrolimus could inhibit the activation of T cells and therefore reduce the incidence of rejection after organ transplantation (Miroux et al. 2012; Veitch et al. 2023).”
Smirnova, T. O., Евгеньевич, С. В., Parinov, O. V., Voskanyan, S. E., Karpenkova, V. I., Solovyova, E. A., & Рудаков, В. С. (2026) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2026-18-1-80-90
L'innervation en ingénierie dentaire
Kökten, T. (2014) · theses.fr (ABES) · doi:10.70675/c6cbe9aaza85ez435ez84a7zceb5019ed09b
Engineering human Tregs to resist tacrolimus via FKBP12 gene editing
Cier, C. J. R., Valentini, N., Boudreau, G., Delisle, J., & Lamarche, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1756624
Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More?
Knioła, E., Foroncewicz, B., Lerut, J., Pączek, L., & Mucha, K. (2026) · Liver International · doi:10.1111/liv.70659
“CsA alters the function of Tregs by inducing the synthesis of IL-2 and INF-γ, dysregulating their suppressive activity [38, 40].”
Features of the course and therapeutic strategy of ulcerative colitis in liver transplant recipients
Smirnova, T. O., Евгеньевич, С. В., Parinov, O. V., & Voskanyan, S. E. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-246-2-61-83
Litjens, N. H. R., Jonker, J., Klepper, M., Prevoo, F., Hesselink, D. A., Bemelman, F. J., Nurmohamed, A. S., van Zuilen, A. D., Berger, S. P., Sanders, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904559
Metadata
- Authors
- Miroux, C., Morales, O., Ghazal, K., Othman, S. B., de Launoit, Y., Pancré, V., Conti, F., & Delhem, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Venue
- Transplantation
- Published
- 2012-07-27
- Volume
- 94
- Issue
- 2
- Pages
- 123-131
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1995250629
- Cited by
- 117
- References
- 46
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 3 · 2016: 5 · 2015: 10 · 2014: 14 · 2013: 4 · 2012: 2
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- cyclosporine, tacrolimus, regulatory T cells, Treg proliferation, immunosuppression, liver transplantation, recurrent hepatitis C, calcineurin inhibitors, NIM811, interleukin-2, graft rejection, Treg suppressive function
- MeSH terms
- Cells, Cultured, Humans, Immunosuppressive Agents, Lymphocyte Activation, Phosphorylation, Liver Transplantation, Immunophenotyping, Cytokines, Tacrolimus, Cyclosporine, T-Lymphocytes, Regulatory, NFATC Transcription Factors, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.